Innate Pharma S.A.
IPHA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21 | -$25 | -$25 | -$9 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $2 | $3 |
| Change in WC | -$10 | $8 | $31 | -$13 |
| Other Non-Cash | -$2 | $4 | -$6 | -$3 |
| Operating Cash Flow | -$31 | -$10 | $3 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $10 | $0 | $0 |
| Other Inv. Act. | $7 | -$1 | $1 | $21 |
| Investing Cash Flow | $7 | $8 | $1 | $21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$9 | -$4 | $0 |
| Stock Issued | $0 | -$0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $15 | $7 | -$0 | -$1 |
| Financing Cash Flow | $10 | -$2 | -$4 | -$1 |
| Forex Effect | $1 | -$0 | -$0 | $0 |
| Net Chg. in Cash | $54 | -$4 | $70 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $70 | $0 | $71 |
| End Cash | $54 | $66 | $70 | $71 |
| Free Cash Flow | -$31 | -$10 | $3 | -$21 |